Construction of tissue-engineered vascular grafts with enhanced patency by integrating heparin, cell-adhesive peptide, and carbon monoxide nanogenerators into acellular blood vessels.
Construction of tissue-engineered vascular grafts with enhanced patency by integrating heparin, cell-adhesive peptide, and carbon monoxide nanogenerators into acellular blood vessels.
复制标题
DOI:
10.1016/j.bioactmat.2023.12.015
复制
发表时间:
2024-04
影响因子:
18.9
通讯作者:
中科院分区:
文献类型:
--
作者:
Small-diameter tissue-engineered vascular grafts (sdTEVGs) have garnered significant attention as a potential treatment modality for vascular bypass grafting and replacement therapy. However, the intimal hyperplasia and thrombosis are two major complications that impair graft patency during transplantation. To address this issue, we fabricated the covalent-organic framework (COF)-based carbon monoxide (CO) nanogenerator-and co-immobilized with LXW-7 peptide and heparin to establish a multifunctional surface on TEVGs constructed from acellular blood vessels for preventing thrombosis and stenosis. The cell-adhesive peptide LXW-7 could capture endothelial-forming cells (EFCs) to promote endothelialization, while the antithrombotic molecule heparin prevented thrombus formation. The reactive oxygen species (ROS)-triggered CO release suppressed the adhesion and activation of macrophages, leading to the reduction of ROS and inflammatory factors. As a result, the endothelial-to-mesenchymal transition (EndMT) triggered by inflammation was restricted, facilitating the maintenance of the homeostasis of the neo-endothelium and preventing pathological remodeling in TEVGs. When transplanted in vivo, these vascular grafts exhibited negligible intimal hyperplasia and remained patent for 3 months. This achievement provided a novel approach for constructing antithrombotic and anti-hyperplastic TEVGs. Tissue-engineered vascular grafts have been constructed by integrating heparin, cell-adhesive peptide, and carbon monoxide nanogenerators into acellular blood vessels. The cell-adhesive peptide can capture endothelial-forming cells to promote endothelialization, while the heparin immobilization facilitates the inhibition of thrombus formation. Reactive oxygen species-triggered carbon monoxide release can eliminate endothelial-to-mesenchymal transition-induced pathological remodeling in the TEVGs by promoting inflammatory resolution. These multifunctional tissue-engineered vascular grafts have shown enhanced patency without thrombosis and severe intimal hyperplasia during implantation.
登录
查看更多内容
影响因子:
4.9
作者:
Chen, Wen;Xiao, Li;Zhu, Chuhong
通讯作者:
Zhu, Chuhong
DOI:
10.34133/2022/9845459
发表时间:
2022
期刊:
Research (Washington, D.C.)
影响因子:
--
作者:
Chen L;Zhou Z;Hu C;Maitz MF;Yang L;Luo R;Wang Y
通讯作者:
Wang Y
DOI:
10.1152/ajpheart.01277.2005
发表时间:
2006-09-01
影响因子:
4.8
作者:
Gonzalez-Pacheco, Francisco R.;Deudero, Juan J. P.;Caramelo, Carlos
通讯作者:
Caramelo, Carlos
影响因子:
10.8
作者:
Diez, Marta;Musri, Melina M.;Peinado, Victor I.
通讯作者:
Peinado, Victor I.
影响因子:
18.9
作者:
Li Y;Wang Y;Xue F;Feng X;Ba Z;Chen J;Zhou Z;Wang Y;Guan G;Yang G;Xi Z;Tian H;Liu Y;Tan J;Li G;Chen X;Yang M;Chen W;Zhu C;Zeng W
通讯作者:
Zeng W